64.72
0.56%
+0.36
アフターアワーズ:
64.65
-0.07
-0.11%
Globus Medical Inc (GMED) 最新ニュース
Key Takeaways From Globus Medical Analyst Ratings
Benzinga
GMED or PEN: Which Is the Better Value Stock Right Now?
Zacks Investment Research
Globus Medical, Inc. (GMED) Hit a 52 Week High, Can the Run Continue?
Zacks Investment Research
Why Globus Medical (GMED) is a Top Value Stock for the Long-Term
Zacks Investment Research
Globus Medical (GMED) Q1 Earnings Top Estimates, Margins Fall
Zacks Investment Research
Globus Medical (GMED) Q1 2024 Earnings Call Transcript
The Motley Fool
Globus Medical (GMED) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
Zacks Investment Research
Globus Medical (GMED) Q1 Earnings and Revenues Beat Estimates
Zacks Investment Research
Globus Medical Reports First Quarter 2024 Results
GlobeNewswire Inc.
Wall Street's Insights Into Key Metrics Ahead of Globus Medical (GMED) Q1 Earnings
Zacks Investment Research
GMED vs. PEN: Which Stock Is the Better Value Option?
Zacks Investment Research
Globus Medical Schedules First Quarter Earnings Release and Conference Call
GlobeNewswire Inc.
Why Globus Medical (GMED) is a Top Momentum Stock for the Long-Term
Zacks Investment Research
Globus Medical (GMED) Gains From New Launches Amid Macro Issues
Zacks Investment Research
Are You a Value Investor? This 1 Stock Could Be the Perfect Pick
Zacks Investment Research
Globus Medical (GMED) Down 5.8% Since Last Earnings Report: Can It Rebound?
Zacks Investment Research
The Latest Analyst Ratings For Globus Medical
Benzinga
Why This 1 Value Stock Could Be a Great Addition to Your Portfolio
Zacks Investment Research
Here's Why You Should Retain Globus Medical (GMED) Stock Now
Zacks Investment Research
Here's Why Globus Medical (GMED) is a Strong Value Stock
Zacks Investment Research
Here's Why Globus Medical (GMED) is a Strong Momentum Stock
Zacks Investment Research
Key Takeaways From Globus Medical Analyst Ratings
Benzinga
Globus Medical (GMED) Q4 Earnings Surpass, Margins Down
Zacks Investment Research
Globus Medical (GMED) Q4 2023 Earnings Call Transcript
The Motley Fool
Compared to Estimates, Globus Medical (GMED) Q4 Earnings: A Look at Key Metrics
Zacks Investment Research
Globus Medical (GMED) Q4 Earnings and Revenues Beat Estimates
Zacks Investment Research
Globus Medical Reports Fourth Quarter and Full Year 2023 Results
GlobeNewswire Inc.
Higher Visits to Soften Cost Blow for Teladoc (TDOC) Q4 Earnings
Zacks Investment Research
Can Low Patient Days Affect Community Health (CYH) Q4 Earnings?
Zacks Investment Research
Will Nevro (NVRO) Report Negative Earnings Next Week? What You Should Know
Zacks Investment Research
Globus Medical (GMED) Q4 Earnings on the Horizon: Analysts' Insights on Key Performance Measures
Zacks Investment Research
The Zacks Analyst Blog Highlights Globus Medical, Glaukos, PROCEPT, Edwards Lifesciences and Quest Diagnostics
Zacks Investment Research
Globus Medical Schedules Fourth Quarter and Full Year 2023 Earnings Release and Conference Call
GlobeNewswire Inc.
Globus Medical (GMED) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Zacks Investment Research
3 Medtech Stocks Likely to Top Estimates This Earnings Season
Zacks Investment Research
Can Tenet's (THC) Q4 Earnings Beat on Rising Patient Admissions?
Zacks Investment Research
Globus Medical promotes Keith Pfeil to Chief Operating Officer and Chief Financial Officer
GlobeNewswire Inc.
Encompass Health (EHC) to Post Q4 Earnings: What's in Store?
Zacks Investment Research
Will High Medical Costs Affect Centene's (CNC) Q4 Earnings?
Zacks Investment Research
Cigna (CI) to Report Q4 Earnings: Can Rising Expenses Hurt?
Zacks Investment Research
Do Investors Have Too Much Money Out of the Market?
The Motley Fool
Will Globus Medical (GMED) Beat Estimates Again in Its Next Earnings Report?
Zacks Investment Research
Can Higher Costs Affect HCA Healthcare's (HCA) Q4 Earnings?
Zacks Investment Research
Here's Why You Should Retain Globus Medical (GMED) Stock Now
Zacks Investment Research
The Analyst Verdict: Globus Medical In The Eyes Of 6 Experts
Benzinga
Globus Medical Reports Preliminary Record Fourth Quarter and Full Year Sales Results
GlobeNewswire Inc.
Is SPDR S&P Health Care Equipment ETF (XHE) a Strong ETF Right Now?
Zacks Investment Research
Globus Medical (GMED) Gains From Innovation Amid Macro Issues
Zacks Investment Research
Should You Invest in the SPDR S&P Health Care Equipment ETF (XHE)?
Zacks Investment Research
Assessing Globus Medical: Insights From 5 Financial Analysts
Benzinga
大文字化:
|
ボリューム (24 時間):